Related Experiment Video
Updated: Sep 19, 2025

Hydra, a Computer-Based Platform for Aiding Clinicians in Cardiovascular Analysis and Diagnosis
Published on: September 26, 2018
Novel Concepts for the Estimation of Lifetime Cardiovascular Risk
Marco Zuin1,2, Claudio Bilato3, Pier Luigi Temporelli4
1Department of Cardio-Thoraco-Vascular Sciences and Public Health, University of Padova, Padua, Italy. zuinml@yahoo.it.
Insights
Lifetime cardiovascular disease (CVD) risk assessment offers a more comprehensive view than short-term models, especially for younger individuals and women. This approach improves CVD prevention strategies by considering broader risk factors and competing risks.
Area of Science:
- Cardiology
- Preventive Medicine
- Public Health
Background:
- Cardiovascular diseases (CVDs) are a leading global cause of mortality and disability.
- Current risk assessment models primarily focus on short-term (10-year) CVD risk.
- Short-term risk estimates often underestimate the lifetime CVD risk, particularly in women and younger populations.
Purpose of the Study:
- To review emerging strategies for estimating lifetime cardiovascular disease (CVD) risk.
- To explore the clinical utility of lifetime CVD risk assessment in daily practice.
- To highlight the benefits for both primary and secondary CVD prevention.
Main Methods:
- Literature review of recent strategies for lifetime CVD risk estimation.
- Analysis of how lifetime risk assessment incorporates traditional and non-traditional risk factors.
- Consideration of competing risks in comprehensive CVD risk profiling.
Main Results:
- Lifetime CVD risk assessment provides a more accurate and tailored evaluation of a patient's health status.
- Individuals with low to moderate short-term risk often account for a significant proportion of CVD events.
- Lifetime risk models offer a broader perspective beyond traditional short-term predictions.
Conclusions:
- Estimating lifetime CVD risk is crucial for effective and personalized prevention strategies.
- This approach can better identify individuals who may benefit from early or intensified interventions.
- Lifetime CVD risk assessment enhances clinical decision-making in managing cardiovascular health.
Abstract:
Cardiovascular diseases (CVDs) remain the leading cause of death and disability worldwide. Over the last two decades, different risk score models, generally assessing the short-term (10-year) risk estimates, have been developed to predict risk and to provide guidance for informed decision-making regarding initiation or intensification of CVD prevention strategies. However, the short-term risk estimation of CVD mortality/morbidity deeply underestimates the lifetime CVD risk, especially in younger age individuals and in women. Moreover, the greatest number of CV events occurs in subjects with low/moderate short-term risk because they are prevalent in the general population. By contrast, estimates of the lifetime risk of CVD may provide a more comprehensive assessment by considering both traditional and non-traditional CV risk factors as well as the potential competing risks, which leads to a more accurate and tailored assessment of the patient's health status. Aim of the present manuscript is to review the latest proposed strategies regarding the estimation of lifetime CV risk and how these strategies may be helpful in daily clinical practice both in primary and secondary prevention.
More Related Videos
02:47Author Spotlight: Exercise Test for Evaluation of the Functional Efficacy of the Pig Cardiovascular System
Published on: May 12, 2023
13:07Optical Coherence Tomography Based Biomechanical Fluid-Structure Interaction Analysis of Coronary Atherosclerosis Progression
Published on: January 15, 2022
Related Concept Videos
Blood Studies for Cardiovascular System I: Cardiac Biomarkers
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Assessment of the Cardiovascular System I: Subjective Data
Initial Enquiry
Ask the patient about their primary concern and thoroughly explore all reported symptoms.
Medical History
Investigate past illnesses affecting the cardiovascular system, such as angina, anemia, rheumatic fever, congenital heart disease, stroke, thrombophlebitis, dysrhythmias, varicosities
Inquire about symptoms...
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Coronary Artery Disease I: Introduction
Coronary Artery Disease IV: Preventive Measures
Blood Studies for Cardiovascular System III: Serum Lipid Profile
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...